Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
5-HT3 antagonist.
COVID-19 research
Cysteine-ITC conjugate.
Oxidized non-cylic hexose sugar.
Sesquiterpene found in various plant sources. <...
Smo inhibitor.
Calcitonin-family peptide, involved in vasodila...
Anthracycline, DNA intercalator; topoisomerase ...
Kavalactone originally found in Piper methystic...
Organosulfur found in Allium; analog of alliin....
Thienylbutyl ITC analog.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Orexin 2 receptor antagonist
Caspase 9 substrate.
Synthetic glucocorticoid
Phytoalexin
Naturally sourced ITC, sulfonyl analog of sulfo...
Statin; HMG-CoA reductase inhibitor.
Naturally occuring isothiocyanate found in broc...
Pt-based DNA cross-linker.